Details for New Drug Application (NDA): 202544
✉ Email this page to a colleague
The generic ingredient in TELMISARTAN AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; telmisartan. There are thirty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; telmisartan profile page.
Summary for 202544
Tradename: | TELMISARTAN AND HYDROCHLOROTHIAZIDE |
Applicant: | Glenmark Pharms Ltd |
Ingredient: | hydrochlorothiazide; telmisartan |
Patents: | 0 |
Pharmacology for NDA: 202544
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 202544
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TELMISARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; telmisartan | TABLET;ORAL | 202544 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-840 | 68462-840-13 | 3 BLISTER PACK in 1 CARTON (68462-840-13) / 10 TABLET in 1 BLISTER PACK |
TELMISARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; telmisartan | TABLET;ORAL | 202544 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-841 | 68462-841-13 | 3 BLISTER PACK in 1 CARTON (68462-841-13) / 10 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;40MG | ||||
Approval Date: | Mar 4, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;80MG | ||||
Approval Date: | Mar 4, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;80MG | ||||
Approval Date: | Mar 4, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription